HomeIndicesNIFTY PHARMAPE Ratio

NIFTY PHARMA Index PE Ratio

48.76

The NIFTY PHARMA P/E ratio is 48.76 on a market cap weighted basis, derived from the price-to-earnings data of 20 of 20 index constituents with valid EPS. Of these, 1 stocks trade at a low P/E ratio below 15, 2 at moderate valuations between 15 and 25, 11 at elevated earnings multiples between 25 and 50, and 6 at very high valuations above 50. For live index level, EPS data and the full index overview, see NIFTY PHARMA constituents list. Use the NIFTY PHARMA PE ratio screener below to analyse the historical valuation trend, EPS distribution, and stock-level price-to-earnings data across all 20 constituents.

48.76
Market Cap Weighted PE
20
Companies with PE Data
12
Historical Data Points

NIFTY PHARMA PE Ratio Distribution — Low, Moderate, High & Very High

1 low (<15), 2 moderate (15–25), 11 high (25–50), 6 very high (50+) among 20 NIFTY PHARMA stocks. Check NIFTY PHARMA market capitalization to monitor the combined market capitalisation of all constituents.

0-15 (Low)
1
Companies
15-25 (Moderate)
2
Companies
25-50 (High)
11
Companies
50+ (Very High)
6
Companies

NIFTY PHARMA PE Ratio Historical Trend — 6 Years

Market cap weighted P/E of NIFTY PHARMA over 6 years — 20 stocks with valid EPS, current P/E 48.76. See NIFTY PHARMA sector weightage analysis to track constituent weightings and sector allocation.

NIFTY PHARMA Component Stocks — P/E Ratio & EPS

20 of 20 NIFTY PHARMA constituents with valid P/E — sorted by market cap weight.

Company Sector Market Cap EPS PE Ratio
SUNPHARMA
Sun Pharmaceutical
Healthcare ₹4.5 Lakh Cr ₹45.60 40.8
DIVISLAB
Divis Laboratories
Healthcare ₹1.8 Lakh Cr ₹82.53 74.1
TORNTPHARM
Torrent Pharmaceuticals
Healthcare ₹1.5 Lakh Cr ₹56.47 65.6
CIPLA
Cipla
Healthcare ₹1.2 Lakh Cr ₹48.03 29.9
DRREDDY
Dr Reddys Laboratories
Healthcare ₹1.1 Lakh Cr ₹50.41 26.8
MANKIND
Mankind Pharma
Healthcare ₹1.0 Lakh Cr ₹49.28 56.4
LUPIN
Lupin
Healthcare ₹1.0 Lakh Cr ₹128.45 19.4
ZYDUSLIFE
Zydus Life Science
Healthcare ₹1.0 Lakh Cr ₹44.97 19.9
AUROPHARMA
Aurobindo Pharma
Healthcare ₹87.8K Cr ₹59.81 25.2
LAURUSLABS
Laurus Labs
Healthcare ₹71.5K Cr ₹16.47 79.8
BIOCON
Biocon
Healthcare ₹69.7K Cr ₹2.82 183.8
GLENMARK
Glenmark Pharmaceuticals
Healthcare ₹65.6K Cr ₹37.11 62.0
ALKEM
Alkem Laboratories
Healthcare ₹65.6K Cr ₹181.11 27.5
ABBOTINDIA
Abbott
Healthcare ₹59.3K Cr ₹730.36 38.3
IPCALAB
IPCA Laboratories
Healthcare ₹40.7K Cr ₹29.08 42.7
AJANTPHARM
Ajanta Pharma
Healthcare ₹39.7K Cr ₹84.53 38.6
JBCHEPHARM
J B Chemicals and Pharmaceuticals
Healthcare ₹34.1K Cr ₹45.16 48.4
GLAND
Gland Pharma
Healthcare ₹30.8K Cr ₹42.40 36.9
NATCOPHARM
Natco Pharma
Healthcare ₹21.5K Cr ₹105.26 13.9
GRANULES
Granules
Healthcare ₹18.2K Cr ₹24.47 30.6

Track NIFTY PHARMA PE Analysis in Your Trading Journal

Use this PE ratio analysis to evaluate index valuation and make informed trading decisions. Monitor how PE trends affect your position sizing and market timing strategies.

Add NIFTY PHARMA Trade to Journal